Slingshot members are tracking this event:
Aimmune's (AIMT) AR101 Peanut Allergy Phase 3 data to be presented February 24 at AAAAI Annual Meeting.
Slingshot Insights Explained
Feb 25, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Ar101, Peanut Allergy, Phase 3 Study, Aaaai Annual Meeting